BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9494556)

  • 21. Kinetics of the inhibition of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom by local anesthetics: procaine and tetracaine.
    al-Jafari AA; Kamal MA; Duhaiman AS; Alhomida AS
    J Enzyme Inhib; 1996 Oct; 11(2):123-34. PubMed ID: 9204401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine.
    Kamal MA; Greig NH; Alhomida AS; Al-Jafari AA
    Biochem Pharmacol; 2000 Aug; 60(4):561-70. PubMed ID: 10874131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mercuric chloride effects on the kinetic parameters of human erythrocyte membrane bound acetylcholinesterase.
    Aijafari AA
    Biochem Mol Biol Int; 1995 Aug; 36(6):1243-53. PubMed ID: 8535296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human erythrocyte acetylcholinesterase inhibition by cis-diamminediaquaplatinum (II): a novel kinetic approach.
    Kamal MA; Nasim FH; Al-Jafari AA
    Cancer Lett; 1999 Apr; 138(1-2):115-9. PubMed ID: 10378782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermodynamic investigation of camel retina acetylcholinesterase inhibition by cyclophosphamide.
    al-Jafari AA; Kamal MA; Alhomida AS
    J Enzyme Inhib; 1997 Feb; 11(4):275-83. PubMed ID: 9208370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The toxicological effect of cyclophosphamide on acetylcholinesterase activity.
    al-Jafari AA
    Toxicol Lett; 1993 Feb; 66(2):125-31. PubMed ID: 8430432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the effect of anti-neoplastic drugs, cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholinesterase.
    Kamal MA; Nasim FH; al-Jafari AA
    Biochem Mol Biol Int; 1996 May; 39(2):293-302. PubMed ID: 8799456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases.
    Khalid A; Zaheer-ul-Haq ; Anjum S; Khan MR; Atta-ur-Rahman ; Choudhary MI
    Bioorg Med Chem; 2004 May; 12(9):1995-2003. PubMed ID: 15080903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics for the inhibition of acetylcholinesterase from human erythrocyte by cisplatin.
    Aljafari AA
    Int J Biochem Cell Biol; 1995 Sep; 27(9):965-70. PubMed ID: 7584632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human platelet acetylcholinesterase inhibition by cyclophosphamide: a combined experimental and computational approach.
    Al-Jafari AA; Shakil S; Reale M; Kamal MA
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):928-35. PubMed ID: 22229321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The preparation and kinetic analysis of multiple forms of human erythrocyte acetylcholinesterase.
    Kamal MA; al-Jafari AA
    Prep Biochem Biotechnol; 1996 May; 26(2):105-19. PubMed ID: 8784921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indirect parasympathomimetic activity of the class III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system.
    Chemnitius JM; Schahmirzadi F; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(5-6):193-200. PubMed ID: 9076843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamic analysis of human retinal acetylcholinesterase inhibition using an anti-Alzheimer's drug, tacrine, through the development of a dual substrate and temperature model.
    Kamal MA; Alhomida AS; Al-Rajhi AA; Al-Jafari AA
    Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):108-15. PubMed ID: 10943943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic evidence for the allosteric substrate inhibition of human erythrocyte acetylcholinesterase.
    Niday E; Wang CS; Alaupovic P
    Biochim Biophys Acta; 1980 Mar; 612(1):67-72. PubMed ID: 7362833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
    Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
    Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
    Hodge AS; Humphrey DR; Rosenberry TL
    Mol Pharmacol; 1992 May; 41(5):937-42. PubMed ID: 1588924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple approaches to analyse the data for rat brain acetylcholinesterase inhibition by cyclophosphamide.
    Kamal MA; Reale M; Al-Jafari AA
    Neurochem Res; 2010 Oct; 35(10):1501-9. PubMed ID: 20652634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization and kinetic studies of human erythrocyte membrane-bound acetylcholinesterase.
    al-Jafari AA; Kamal MA
    Biochem Mol Biol Int; 1996 Mar; 38(3):577-86. PubMed ID: 8829618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.